header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

Trauma

THE CHERTSEY EXPERIENCE OF THE MANAGEMENT OF ACUTE AND CHRONIC TRIMALLEOLAR FRACTURES USING CIRCULAR FRAMES: A CASE SERIES

British Limb Reconstruction Society (BLRS) Annual Conference, Southampton, March 2018



Abstract

Aim

Circular frames are used to treat a wide spectrum of acute injuries and deformities. We report on our experience of treating both acute and chronic trimalleolar fracture dislocations with a closed technique, utilizing fine wires and a circular frame.

Methods

Data was collected from all patients treated for either acute or chronic trimalleolar fracture dislocations at a single centre between January 2016 and December 2017. A total of 10 patients were identified, 8 with acute injuries and 2 with chronic/delayed injuries. Clinical and radiological outcomes were recorded, as well as patient reported outcome measures (PROMs) using the Chertsey Outcome Score for Trauma (COST score).

Results

8 patients were treated for acute trimalleolar fractures, 2 of which were open medially. One patient had sustained a further break and metalwork failure following fixation for trimalleolar fracture at another hospital and 1 patient presented 6 weeks post injury. Average age was 53.6 years (range 20–86). Average time to surgery following acute injury was 4.3 days (0–12). Average follow up to date was 25 weeks (2–60). All patients had satisfactory alignment and union at completion of treatment. The average COST score (n=8) was 52/100 (30–90). 3 patients had pin site infections managed with antibiotics. One patient died due to unrelated medical complications.

Conclusion

Initial use of circular frames for trimalleolar fracture has shown excellent results in terms of radiological, clinical and patient reported outcome measures. Complications have been limited to date.


E-mail: